enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Alnylam Files Clinical Trial Application to Initiate a Phase ...

   www.aol.com/news/2013-01-03-alnylam-files...

   Alnylam intends to focus on developing and commercializing certain programs from this product strategy itself in the United States and potentially certain other countries; the company will seek ...

3. Alnylam Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Alnylam_Pharmaceuticals

   Alnylam still does not earn money, but writes losses. The losses ("GAAP Operating Loss") from Alnylam were around $650 million in the late 2020. Alnylam expects to achieve net profits financially in 2022 or 2023. [40] In July 2023, Roche partnered with Alnylam Pharmaceuticals in a deal worth $2.8 billion for the development of a hypertension ...

4. The Medicines Company Licenses Alnylam's Cholesterol Program

   www.aol.com/news/2013-02-04-the-medicines...

   The Medicines Company has licensed Alnylam Pharmaceuticals' cholesterol-lowering ALN-PCS RNAi therapeutic program, the companies announced today. Alnylam is due $25 million upfront from The ...

5. Internship - Wikipedia

   en.wikipedia.org/wiki/Internship

   Unpaid internships are typically through non-profit charities and think tanks which often have unpaid or volunteer positions. State law and state enforcement agencies may impose requirements on unpaid internship programs under Minimum Wage Act. A program must meet criteria to be properly classified as an unpaid internship.

6. Yvonne Greenstreet - Wikipedia

   en.wikipedia.org/wiki/Yvonne_Greenstreet

   Greenstreet became Alnylam's chief operating officer in 2016. In 2021, it was announced that John Maraganore would step down as Alnylam's CEO on 1 January 2022, and would be succeeded by Greenstreet. [1]

7. Alnylam Files Clinical Trial Application for ALN-AAT02 in UK

   www.aol.com/news/alnylam-files-clinical-trial...

   Alnylam Pharmaceuticals (ALNY) submits a Clinical Trial Authorization application in the U.K. to start a phase I/II study on its early stage candidate, ALN-AAT02, for treating alpha-1 liver disease.

8. Internship (medicine) - Wikipedia

   en.wikipedia.org/wiki/Internship_(medicine)

   The program for a degree of "Médico cirujano" or "Médico Integral Comunitario" [26] [circular reference] during the final year or one and a half year, depending on the university program, has a compulsory internship program under the supervision of qualified licensed doctors at a type III or IV hospital. During this time, students undergo ...

9. Analysts Put Alnylam On Upside Catalyst Watch Ahead Of ... - AOL

   www.aol.com/news/analysts-put-alnylam-upside...

   Related: Alnylam Shares Detailed Patisiran Data From Rare Disease Study. The base business continues to perform, and POC for Alzheimer's Analysts Put Alnylam On Upside Catalyst Watch Ahead Of ...